pharmacomechanical thrombolysis
Pronunciation: far-mah-koh-meh-KAN-ih-kal throm-BOL-ih-sis
Combined approach using mechanical devices and clot-dissolving drugs to remove blood clots from vessels.
Full Definition
Pharmacomechanical thrombolysis is an advanced treatment technique that combines mechanical clot disruption with pharmaceutical thrombolytic agents to achieve rapid and effective clot removal from blood vessels. This approach utilizes specialized catheter-based devices that mechanically fragment thrombus while simultaneously delivering thrombolytic drugs directly to the clot site. The mechanical component accelerates clot breakdown and increases the surface area exposed to thrombolytic agents, potentially reducing drug doses and treatment times compared to pharmacological thrombolysis alone. This technique is commonly used in treating acute deep vein thrombosis, pulmonary embolism, and acute limb ischemia when rapid restoration of blood flow is critical.
Usage
Usage note: Specify device type and thrombolytic agent used in procedure documentation.
In Context
- "Pharmacomechanical thrombolysis achieved complete clot lysis within 12 hours of treatment initiation." — interventional procedure report
- "The patient underwent pharmacomechanical thrombolysis using a rotating device with concurrent tissue plasminogen activator infusion." — treatment protocol documentation